siRNA therapy lowers triglycerides in patients along with rare problem

.RESEARCH FEATURE.19 September 2024. Plozasiran minimized triglyceride amounts through 80% as well as lowered the threat of pancreatitis in individuals with chronic chylomicronemia, with or even without a genetic diagnosis.